Ballentine Partners’s UnitedHealth UNH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.5M | Buy |
15,641
+570
| +4% | +$211K | 0.08% | 89 |
|
|
2026
Q1 | $4.08M | Sell |
15,071
-1,648
| -10% | -$491K | 0.06% | 111 |
|
|
2025
Q4 | $5.52M | Buy |
16,719
+550
| +3% | +$186K | 0.08% | 90 |
|
|
2025
Q3 | $5.58M | Sell |
16,169
-80
| -0.5% | -$24.2K | 0.08% | 85 |
|
|
2025
Q2 | $5.07M | Sell |
16,249
-1,301
| -7% | -$497K | 0.08% | 91 |
|
|
2025
Q1 | $9.19M | Buy |
17,550
+448
| +3% | +$229K | 0.16% | 55 |
|
|
2024
Q4 | $8.65M | Sell |
17,102
-229
| -1% | -$130K | 0.15% | 55 |
|
|
2024
Q3 | $10.1M | Buy |
17,331
+809
| +5% | +$458K | 0.17% | 49 |
|
|
2024
Q2 | $8.41M | Sell |
16,522
-2,981
| -15% | -$1.46M | 0.16% | 51 |
|
|
2024
Q1 | $9.65M | Sell |
19,503
-229
| -1% | -$116K | 0.18% | 47 |
|
|
2023
Q4 | $10.4M | Buy |
19,732
+1,378
| +8% | +$735K | 0.21% | 46 |
|
|
2023
Q3 | $9.25M | Buy |
18,354
+1,139
| +7% | +$561K | 0.22% | 46 |
|
|
2023
Q2 | $8.27M | Buy |
17,215
+4,277
| +33% | +$2.09M | 0.19% | 48 |
|
|
2023
Q1 | $6.11M | Sell |
12,938
-2,320
| -15% | -$1.12M | 0.15% | 51 |
|
|
2022
Q4 | $8.09M | Buy |
15,258
+1,624
| +12% | +$860K | 0.24% | 42 |
|
|
2022
Q3 | $6.88M | Buy |
13,634
+1,536
| +13% | +$808K | 0.24% | 40 |
|
|
2022
Q2 | $6.21M | Buy |
12,098
+1,000
| +9% | +$502K | 0.22% | 43 |
|
|
2022
Q1 | $5.66M | Buy |
11,098
+359
| +3% | +$173K | 0.18% | 50 |
|
|
2021
Q4 | $5.39M | Buy |
10,739
+1,727
| +19% | +$782K | 0.16% | 52 |
|
|
2021
Q3 | $3.52M | Buy |
9,012
+36
| +0.4% | +$14.9K | 0.12% | 62 |
|
|
2021
Q2 | $3.59M | Buy |
8,976
+24
| +0.3% | +$9.57K | 0.12% | 58 |
|
|
2021
Q1 | $3.33M | Sell |
8,952
-133
| -1% | -$46.1K | 0.12% | 58 |
|
|
2020
Q4 | $3.19M | Sell |
9,085
-1,462
| -14% | -$490K | 0.13% | 55 |
|
|
2020
Q3 | $3.29M | Sell |
10,547
-939
| -8% | -$288K | 0.15% | 54 |
|
|
2020
Q2 | $3.39M | Sell |
11,486
-1,889
| -14% | -$541K | 0.16% | 52 |
|
|
2020
Q1 | $3.34M | Buy |
13,375
+3,241
| +32% | +$892K | 0.19% | 50 |
|
|
2019
Q4 | $2.98M | Sell |
10,134
-199
| -2% | -$52.1K | 0.14% | 64 |
|
|
2019
Q3 | $2.25M | Buy |
10,333
+140
| +1% | +$33.8K | 0.11% | 85 |
|
|
2019
Q2 | $2.49M | Buy |
10,193
+834
| +9% | +$201K | 0.12% | 79 |
|
|
2019
Q1 | $2.31M | Buy |
9,359
+209
| +2% | +$53.3K | 0.12% | 66 |
|
|
2018
Q4 | $2.28M | Buy |
9,150
+53
| +0.6% | +$14K | 0.13% | 63 |
|
|
2018
Q3 | $2.42M | Buy |
9,097
+59
| +0.7% | +$15.3K | 0.13% | 66 |
|
|
2018
Q2 | $2.22M | Buy |
9,038
+202
| +2% | +$48.5K | 0.12% | 62 |
|
|
2018
Q1 | $1.89M | Sell |
8,836
-958
| -10% | -$219K | 0.11% | 66 |
|
|
2017
Q4 | $2.16M | Sell |
9,794
-1,917
| -16% | -$406K | 0.12% | 64 |
|
|
2017
Q3 | $2.29M | Buy |
11,711
+237
| +2% | +$45.8K | 0.13% | 61 |
|
|
2017
Q2 | $2.18M | Buy |
11,474
+1,601
| +16% | +$281K | 0.16% | 64 |
|
|
2017
Q1 | $1.62M | Buy |
9,873
+3,700
| +60% | +$606K | 0.12% | 47 |
|
|
2016
Q4 | $984K | Buy |
6,173
+99
| +2% | +$14.8K | 0.08% | 68 |
|
|
2016
Q3 | $850K | Buy |
6,074
+430
| +8% | +$60.2K | 0.07% | 68 |
|
|
2016
Q2 | $797K | Buy |
5,644
+230
| +4% | +$30.7K | 0.07% | 79 |
|
|
2016
Q1 | $698K | Buy |
5,414
+750
| +16% | +$88.7K | 0.06% | 87 |
|
|
2015
Q4 | $548K | Buy |
4,664
+897
| +24% | +$105K | 0.05% | 88 |
|
|
2015
Q3 | $437K | Buy |
3,767
+357
| +10% | +$42.7K | 0.05% | 98 |
|
|
2015
Q2 | $416K | Buy |
3,410
+32
| +0.9% | +$3.79K | 0.04% | 106 |
|
|
2015
Q1 | $399K | Buy |
3,378
+536
| +19% | +$59.5K | 0.04% | 106 |
|
|
2014
Q4 | $288K | Sell |
2,842
-162
| -5% | -$15.4K | 0.03% | 126 |
|
|
2014
Q3 | $259K | Buy |
3,004
+313
| +12% | +$26.4K | 0.03% | 128 |
|
|
2014
Q2 | $220K | Sell |
2,691
-96
| -3% | -$7.55K | 0.03% | 129 |
|
|
2014
Q1 | $228K | Buy |
+2,787
| New | +$210K | 0.03% | 128 |
|
Other funds holding UNH
LMFP
PAM
DC
FWIA
OIAM
CNB
Ballentine Partners's UNH Position: Q2 2026 in Review
Ballentine Partners increased its UnitedHealth (UNH) stake by 3.8% in Q2 2026, buying an estimated $211K and bringing the position to 15,641 shares worth $6.5M. The position accounts for 0.08% of the portfolio, ranked #89.
Ballentine Partners first reported a position in UNH in Q1 2014 and has held it in 50 quarters since. The position peaked at $10.4M in Q4 2023. 568 funds tracked by Wall St. Rank hold UNH as of Q2 2026.
- Ballentine Partners held 15,641 shares of UnitedHealth worth $6.5M as of Q2 2026.
- Ballentine Partners bought 570 UnitedHealth shares in Q2 2026, an estimated $211K.
- UnitedHealth made up 0.08% of Ballentine Partners's portfolio in Q2 2026, its #89 holding.
- Ballentine Partners first reported a position in UnitedHealth in Q1 2014 and has held it in 50 quarters since.
- Ballentine Partners's UnitedHealth position peaked at $10.4M in Q4 2023.
- 568 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2026.
Based on Ballentine Partners's 13F filing for Q2 2026, filed 17 Jul 2026.